La Vecchia, Giulia
Del Buono, Marco Giuseppe
Bonaventura, Aldo
Vecchiè, Alessandra
Moroni, Francesco
Sanna, Tommaso
Abbate, Antonio
Funding for this research was provided by:
Università Cattolica del Sacro Cuore
Article History
Accepted: 31 October 2024
First Online: 8 January 2025
Declarations
:
: Dr. Bonaventura serves on the scientific advisory board for Monte Rosa Therapeutics. Dr. Abbate has served as a consultant to Novo Nordisk, Monterosa Tx, and Kiniksa; and he also served on the Data Safety Monitoring Board/Advisory Board for Applied Therapeutic Inc. Dr. Sanna serves as a consultant to Medtronic. The other authors declare that they have no conflict of interest.The authors declare no competing interests.
: This article does not contain any studies with human or animal subjects performed by any of the authors.